STAT+: Policy experts call on Medicare to ensure data from Alzheimer’s drug registries is shared publicly
More than two dozen prominent health policy experts are urging the Biden administration to ensure…
Category: Medicare
STAT+: Senate panel advances PBM reform — but sidesteps anything controversial
WASHINGTON — Senators on the Finance Committee on Wednesday nearly unanimously passed a bill to…
STAT+: Democrats decry a new health package as too easy on private equity
WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display…
.jpg)
STAT+: Democrats already want to expand Medicare’s drug price negotiation
WASHINGTON — It’s drug pricing déjà vu: Just as they did in 2019, House Democrats…
STAT+: Congress’s PBM reforms won’t end America’s drug pricing woes. Here’s what they would do
WASHINGTON — Lawmakers in Congress generally agree that there’s something very broken with the way America…
STAT+: Pharmalittle: Biogen to slash 1,000 more jobs; key House panel proposes lowering Medicare out-of-pocket drug costs
Rise and shine, everyone, another busy day is on the way. This morning is getting…
STAT+: Key House panel proposes lowering out-of-pocket drug costs in Medicare
WASHINGTON — A key House committee announced their own plans to increase health care transparency…
STAT+: Bernie Sanders wants to replace drug patents with prizes for breakthrough medicines
WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to…
STAT+: Hospitals struggle to make money on CAR-T cancer therapies, but their fortunes may change
WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer…
STAT+: Johnson & Johnson sues to stop Medicare negotiation
WASHINGTON — Pharmaceutical giant Johnson & Johnson on Tuesday became the third drugmaker to sue the…
STAT+: Conservative group opposing PBM reform spends record number on lobbying
WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than…
STAT+: Medicare has a new plan to address drug shortages — but it could backfire
WASHINGTON — Medicare has a new proposal to pay hospitals more to stockpile essential drugs…
Hearing aids may slow mental decline in those at higher risk of dementia, study finds
Doctors have long suspected that hearing loss in older adults hastens dementia, the cognitive decline…
STAT+: Medicare to cover more brain scans for Alzheimer’s patients
WASHINGTON — Medicare on Monday proposed ending restrictions on how many PET scans patients can…
STAT+: Key House panel plots a new health care package — complicating the chamber’s agenda
WASHINGTON — It’s two weeks until Congress leaves town in August, and a prominent House panel…
Opinion: Congress can eradicate hepatitis C and reduce the deficit at the same time
Congress faces a historic opportunity to stamp out a disease that kills thousands of Americans…
STAT+: Medicare eyes cuts to doctors, raises to outpatient clinics in 2024
Physicians are in line to absorb more Medicare cuts next year, while hospital outpatient departments…
STAT+: How a key Senate committee is planning to regulate pharmacy benefit managers
WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms…
STAT+: Medicare wants to send $9 billion to 340B hospitals — coupled with cuts
WASHINGTON — Medicare is planning to send $9 billion in lump sum payments to more…
STAT+: Home health providers sue Medicare over payment cuts, despite near record profits
The National Association of Home Care and Hospice sued the Biden administration to halt the…
Most ambulances ‘run hot’ with lights and sirens blaring. But that’s starting to change
Jonathan Studnek knows some people imagine that driving an ambulance at high speed with lights…
STAT+: Bright Health sells Medicare Advantage plans to Molina for $600 million
Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded…
STAT+: Medicare details the structure of its new drug price negotiation program
WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation…
STAT+: Medicare’s new proposal to cover medical devices draws a mixed reaction
The medical device industry is split on whether a proposed new Medicare reimbursement pathway will…
STAT+: Protestors slam health insurance lobby for Medicare Advantage coverage restrictions
WASHINGTON — Hundreds of activists rallied today outside of the headquarters of the country’s largest…
STAT+: Grail faces uphill battle to get Medicare to cover its cancer screening test
WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test…
STAT+: UnitedHealth wins $3.3 billion takeover of home health giant Amedisys
Home health and hospice chain Amedisys has chosen a new corporate owner. Amedisys and UnitedHealth…
.jpg)
CMS proposes new pathway for reimbursing breakthrough devices
Medical device makers may soon have an easier path to securing health insurance reimbursement for…
STAT+: Congress explores changes to the way Medicare pays doctors
Congress is taking early steps towards changing the way Medicare pays physicians. At a hearing…
STAT+: Medicare puts out new details for covering the Alzheimer’s drug Leqembi, as the health system readies for potential approval
WASHINGTON — The health care system is on the precipice of broad access to a treatment…
STAT+: The strategy behind the pharmaceutical industry’s flurry of lawsuits challenging drug pricing reform
WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere….
STAT+: Doctors’ lobby doubles down on the fight against expanding open access to research
Doctors’ lobbyists in Washington tend to focus their energies on ensuring Medicare pays well, and…
STAT+: PhRMA sues Biden administration over Medicare drug price negotiation program
WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle…
STAT+: How drug pricing reforms are affecting Bayer’s investments
WASHINGTON — Pharma companies have long been warning Democrats’ drug pricing reforms could discourage investment in…
STAT+: Federal advisory group rejects proposal to make medical device tracking easier
Every medical device has its own unique code, allowing manufacturers to keep track of their…
STAT+: Key House Republican escalates rhetoric against PBMs
WASHINGTON — A key House Republican ramped up his criticism of pharmacy benefit managers Tuesday,…
STAT+: Pharmalittle: U.S. Chamber sues over Medicare price negotiations; FDA seeks new supplier for scarce cancer drug
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Chamber of Commerce tries new legal arguments to challenge Medicare drug-price negotiation
WASHINGTON — The U.S. Chamber of Commerce sued the federal government over its new Medicare drug-price…
STAT+: Top Senate Republican signals interest in site-neutral reform for hospitals
WASHINGTON — A top Senate Republican signaled his interest in pursuing hospital payment reform to…
STAT+: Democrats blast Biden administration over Alzheimer’s drug plans
WASHINGTON — Ahead of a major Food and Drug Administration meeting on a new Alzheimer’s…
‘Tantamount to extortion:’ Merck sues U.S. government over Medicare negotiation program
WASHINGTON — Merck on Tuesday sued to stop the federal government from implementing a new…
STAT+: Medicare taps acting official to head up its new drug price negotiations
WASHINGTON — Medicare has chosen a Center for Medicare and Medicaid Innovation official to temporarily…
For many who use power wheelchairs, CMS decision just made seat elevation much less expensive
This article is adapted from STAT’s latest report, Decoding Medicare: 10 key coverage decisions and…
STAT+: Republicans want to crack down on pricey health regulations, but there are major loopholes
WASHINGTON — At first glance, the debt ceiling deal that Republicans struck with the White…
STAT+: CVS warns PBM reforms ‘could lead to higher costs’
As Congress considers wide-ranging reforms to pharmacy benefit managers, a top executive at CVS Health,…
STAT+: Congress took on high drug prices in Medicare. Now Biden wants to take it to Medicaid
WASHINGTON — The Biden administration wants to help states control Medicaid prescription drug costs by…
Senators probing largest Medicare Advantage plans over how algorithms factor in care denials
Senators warned the country’s largest Medicare Advantage insurers at a hearing on Wednesday that they…
STAT+: House panel takes first steps toward reining in hospitals with ‘site-neutral’ changes
WASHINGTON — A key House panel on Wednesday advanced several health care bills on Wednesday,…
STAT+: Lawmakers press CMS to release new breakthrough device coverage rule
WASHINGTON — An array of lawmakers called for a simpler reimbursement pathway for breakthrough devices…
Gail Wilensky on the Geisinger deal, the earnings bonanza, and medical credit cards proliferate
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…